Navigation Links
Sony Announces World's First Medical-Grade Monitor Utilizing Breakthrough OLED Technology
Date:7/11/2012

PARK RIDGE, N.J., July 11, 2012 /PRNewswire/ -- Sony Electronics is announcing the world's first medical-grade monitor, model PVM-2551MD, based on Organic Light-Emitting Diode (OLED) technology. The new 25-inch monitor, which recently received FDA 510(k) clearance, is expected to deliver significant benefits for a variety of surgical procedures and combines all the noted advantages of Sony's OLED technology -- true-to-life color reproduction, high resolution, and virtually no motion blur. 

(Photo: http://photos.prnewswire.com/prnh/20120711/NY38634)

"Already showing tremendous advantages for surgeons in other parts of the world, the new Sony OLED monitor will now enhance surgical viewing  in the U.S., and become the 'must have' medical display," said George Santanello, general manager, Sony Medical Systems Division.  "A number of Sony's key technology resellers and integrators have already evaluated the display and noted the significant benefits of OLED versus traditional LCD, so we're excited about getting the product into operating rooms across the country."

The majority of surgeons, both in and outside the U.S., who were asked to evaluate Sony's OLED monitors, reported that they prefer OLED's advanced technology for its stability of color imaging and high quality contrast. This technology is expected to set a new standard for medical displays, particularly for applications such as endoscopy, arthroscopy, laparoscopy, and thoracoscopy, as well as general surgery procedures.

Sony's OLED technology is already extremely successful in a range of commercial applications such as critical reference monitoring for video production, with more than 10,000 units delivered worldwide. Now the company expects to see the same rapid adoption by the medical industry.

With its much quicker response time than LCD, one of the greatest advantages of the OLED monitor is its ability to display quick motion with virtually no blur. Additionally, the monitor incorporates Sony's revolutionary TRIMASTER EL technology (EL standing for electroluminescence), enabling it to achieve pure black, faithful to the source signal. By providing superb color reproduction, especially for dark images, surgeons can observe very subtle details such as the faint color difference between various tissues and blood vessels.  This ability to achieve true-to-life color reproduction and reduced blur is expected to support quicker, more confident decision making for surgeons which is ultimately best for patients.

Other features and advantages of the OLED monitor include the following:

  • Self-luminous, emitting no black when displaying images and displaying a high level of contrast
  • 10-bit signal processing
  • Extremely slim and light-weight design
  • Reduced power consumption requirements for increased energy efficiency.

The Sony OLED medical-grade monitor, PVM-2551MD, is currently available for sale with pricing available upon request.


'/>"/>
SOURCE Sony Electronics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
2. Angioslide Announces First Successful Below-The-Knee Procedures in the US
3. CryoLife Announces Release Date and Teleconference Call Details for 2012 Second Quarter Financial Results
4. PTC Therapeutics Announces Achievement of Major Milestone in Wellcome Trust BMI1 Collaboration
5. Lilly Announces Pomaglumetad Methionil Did Not Meet Primary Endpoint of Clinical Study
6. Genova Diagnostics, Inc. Announces the Acquisition of Metametrix, Inc.
7. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
8. Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV
9. Elsevier Announces New Editor-In-Chief for Neurobiology of Learning and Memory
10. Express Scripts Holding Company Announces Second Quarter 2012 Earnings Conference Call
11. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
Breaking Medicine News(10 mins):